AxelaCare Health Solutions, LLC
Welcome,         Profile    Billing    Logout  
 1 Trial 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Allen, Jeffrey C
NF111, NCT04544007: A Phase II Trial of Poly-ICLC for Low-Grade Gliomas

Terminated
2
3
US
Poly ICLC, Hiltonol
University of Alabama at Birmingham, Children's Healthcare of Atlanta, Children's Hospital Los Angeles
NF1, Low-grade Glioma
01/24
11/24
ARDA+, NCT05405361 / 2021-004998-32: A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults with Multifocal Motor Neuropathy

Active, not recruiting
2
51
Europe, Canada, US
ARGX-117, Placebo
argenx, argenx BV
Multifocal Motor Neuropathy (MMN)
09/26
09/26
NCT06106672: Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects with Myasthenia Gravis

Recruiting
1/2
54
US
CNP-106, Placebo
COUR Pharmaceutical Development Company, Inc.
Myasthenia Gravis, Generalized Myasthenia, AChR Myasthenia Gravis, MuSK MG
06/26
08/26
NCT04185935: Molecular Genetics Studies of Cancer Patients and Their Relatives

Recruiting
N/A
999999
US, RoW
Biospecimen Collection, Questionnaire Administration
City of Hope Medical Center, National Cancer Institute (NCI)
Malignant Neoplasm
08/33
08/33
Walton, Timothy
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Allen, Jeffrey C
NF111, NCT04544007: A Phase II Trial of Poly-ICLC for Low-Grade Gliomas

Terminated
2
3
US
Poly ICLC, Hiltonol
University of Alabama at Birmingham, Children's Healthcare of Atlanta, Children's Hospital Los Angeles
NF1, Low-grade Glioma
01/24
11/24
ARDA+, NCT05405361 / 2021-004998-32: A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults with Multifocal Motor Neuropathy

Active, not recruiting
2
51
Europe, Canada, US
ARGX-117, Placebo
argenx, argenx BV
Multifocal Motor Neuropathy (MMN)
09/26
09/26
NCT06106672: Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects with Myasthenia Gravis

Recruiting
1/2
54
US
CNP-106, Placebo
COUR Pharmaceutical Development Company, Inc.
Myasthenia Gravis, Generalized Myasthenia, AChR Myasthenia Gravis, MuSK MG
06/26
08/26
NCT04185935: Molecular Genetics Studies of Cancer Patients and Their Relatives

Recruiting
N/A
999999
US, RoW
Biospecimen Collection, Questionnaire Administration
City of Hope Medical Center, National Cancer Institute (NCI)
Malignant Neoplasm
08/33
08/33
Walton, Timothy
No trials found

Download Options